[Leprosy therapy and pharmacogenetics (author's transl)].
D000123:Acetyltransferases; D002991:Clofazimine / Q000627:therapeutic use; D042966:Cytochrome-B(5) Reductase; D003622:Dapsone / Q000627:therapeutic use / Q000633:toxicity; D005954:Glucosephosphate Dehydrogenase; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D008967:Molecular Biology; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic; D013449:Sulfonamides / Q000627:therapeutic use; D013882:Thiosemicarbazones / Q000627:therapeutic use; D013997:Time Factors
D013449:Sulfonamides; D013882:Thiosemicarbazones; D003622:Dapsone; D002991:Clofazimine; D005954:Glucosephosphate Dehydrogenase; D042966:Cytochrome-B(5) Reductase; D000123:Acetyltransferases
Terapéutica de la lepra y farmacogenética